SLC7A5 and neoplasm: Inhibiting LAT1 can pave a way forsuppressing tumor growth; this approach can also be exploited forthe delivery of antineoplastic drugs into cancer cells via a prodrugstrategy.5,9 Regarding the overexpression pattern ofLAT1 in various cancers, developing radiolabeled selective LAT1 ligandscould be one way to diagnose the presence of malignant cells in peripheraltissues.12,13